Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence

Date: June 23, 2012
Pages: 103
Price:
US$ 1,250.00
License [?]:
Publisher: iCD Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I51FA7969D9EN
Leaflet:

Download PDF Leaflet

Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry  - 2012-2013 : Survey Intelligence
Synopsis
  • Analysis of opinions drawn from leading pharmaceutical industry executives.
  • Provides revenue growth expectations for the period 2012-2013.
  • Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business structure.
  • Analysis of the demand in emerging markets and growth expectations in developed countries.
  • Analysis of the changing business dynamics in the pharmaceutical industry.
  • Analysis of the challenges faced by buyers and suppliers.

Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how business strategies and practices in the pharmaceutical industry are set to change in 2012-13. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope
  • The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
  • This report covers data and analysis on industry developments.
  • Key topics covered include threats and opportunities, economic outlook and business confidence.
  • In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
  • The report examines current practices and provides future expectations for the industry over the next 12-24 months.
  • The report provides qualitative analysis of the key industry threats and opportunities.

Reasons To Buy
  • This report will help you to drive revenues by understanding future product investment areas and growth regions.
  • This report will help you to better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
  • This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
  • This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
  • This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
1 INTRODUCTION

1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
  1.4.1 Profile of buyer respondents: global pharmaceutical industry
  1.4.2 Profile of supplier respondents: global pharmaceutical industry

2 EXECUTIVE SUMMARY

3 GLOBAL PHARMACEUTICAL INDUSTRY DYNAMICS

3.1 Revenue Growth Expectations in the Global Pharmaceutical Industry
  3.1.1 Global pharmaceutical industry: revenue growth expectations by company type
  3.1.2 Global pharmaceutical industry: revenue growth expectations by region
  3.1.3 Global pharmaceutical industry: revenue growth expectations by turnover
  3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
  3.1.5 Global pharmaceutical industry: Revenue growth expectations cross industry comparisons
3.2 Future Developments in Business Structure: Global Pharmaceutical Industry
  3.2.1 Global pharmaceutical industry: future developments by buyers
  3.2.2 Global pharmaceutical industry: future developments by suppliers
  3.2.3 Global pharmaceutical industry: future developments by region
  3.2.4 Global pharmaceutical industry: future developments by company turnover
3.3 M&A Activity Projections in the Global Pharmaceutical Industry
  3.3.1 M&A activity projections in the global pharmaceutical industry by buyers
  3.3.2 M&A activity projections in the global pharmaceutical industry by suppliers
  3.3.3 M&A activity projections in the global pharmaceutical industry by region
  3.3.4 M&A activity projections in the global pharmaceutical industry by company turnover
  3.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections
3.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry
  3.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers
  3.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers
  3.4.3 Capital expenditure forecast in the global pharmaceutical industry by region
  3.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover
3.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry
  3.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers
  3.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers
  3.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region
  3.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover

4 GLOBAL PHARMACEUTICAL INDUSTRY MARKET GROWTH OUTLOOK

4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
  4.1.1 Global pharmaceutical industry: demand in emerging markets by buyers
  4.1.2 Global pharmaceutical industry: demand in emerging markets by suppliers
  4.1.3 Global pharmaceutical industry: demand in emerging markets by region
  4.1.4 Global pharmaceutical industry: demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry: Growth Expectations in Developed Countries
  4.2.1 Global pharmaceutical industry: growth expectations in developed countries by buyers
  4.2.2 Global pharmaceutical industry: growth expectations in developed countries by suppliers
  4.2.3 Global pharmaceutical industry: growth expectations in developed countries by region
  4.2.4 Global pharmaceutical industry: growth expectations in developed countries by company turnover

5 THREATS AND OPPORTUNITIES FOR THE GLOBAL PHARMACEUTICAL INDUSTRY

5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2012 2013
  5.1.1 Global pharmaceutical industry: leading business concerns for 2012 2013 by company type
  5.1.2 Global pharmaceutical industry: leading business concerns for 2012 2013 by region
  5.1.3 Global pharmaceutical industry: leading business concerns for 2012 2013 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Secure Buyer Business
  5.2.1 Global pharmaceutical industry: key actions to secure buyer business (buyer respondents)
  5.2.2 Global pharmaceutical industry: key actions to secure buyer business by region
  5.2.3 Global pharmaceutical industry: key actions to secure buyer business by turnover
  5.2.4 Global pharmaceutical industry: key actions to secure buyer business by procurement budget
  5.2.5 Global pharmaceutical industry: key actions to secure buyer business by purchasing decision authority

6 APPENDIX

6.1 Global Pharmaceutical Industry Survey Results Closed Questions
6.2 Methodology
6.3 Contact us
6.4 About ICD Research
6.5 Disclaimer

LIST OF TABLES

Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010-2012
Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Table 13: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Table 14: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Table 15: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Table 16: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Table 17: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Table 18: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Table 19: M&A Projections: Global CRO and CMO (%), 2010-2012
Table 20: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 21: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Table 22: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Table 23: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Table 24: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Table 25: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Table 26: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Table 27: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Table 28: Staff Recruitment by Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Table 30: Global Pharmaceutical Industry Staff Recruitment by Turnover (%), 2012
Table 31: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012
Table 32: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012
Table 33: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012
Table 34: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012
Table 35: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012
Table 36: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012
Table 37: Global Pharmaceutical Industry: Leading Concerns (%), 2010-2012
Table 38: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012-2013
Table 39: Global Pharmaceutical Industry: Leading Business Concerns by Region (%), 2012-2013
Table 40: Global Pharmaceutical Industry: Leading Business Concerns by Turnover (%), 2012-2013
Table 41: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012
Table 42: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012
Table 43: Actions to Maintain and Secure Buyer Business by Region (%), 2012
Table 44: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012
Table 45: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2012
Table 46: Survey Results - Closed Questions

LIST OF FIGURES

Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010-2012
Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010-2012
Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010-2012
Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012
Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012
Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012
Figure 7: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012
Figure 8: Key Changes In Business Structure: Global CRO and CMO (%), 2012
Figure 9: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012
Figure 10: Global Pharmaceutical Industry: Future Developments by Region (%), 2012
Figure 11: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012
Figure 12: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010-2012
Figure 13: M&A Projections: Global CRO and CMO Industry (%), 2010-2012
Figure 14: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Figure 15: Global Pharmaceutical Industry M&A Projections by Region (%), 2012
Figure 16: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012
Figure 17: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012
Figure 18: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012
Figure 19: Capital Expenditure Forecast by Global CRO and CMO (%), 2012
Figure 20: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012
Figure 21: Global Pharmaceutical Industry Capital Expenditure Forecast by Region (%), 2012
Figure 22: Global Pharmaceutical Industry Capital Expenditure Forecast by Turnover (%), 2012
Figure 23: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012
Figure 24: Planned Change in Staff Hiring Activities by Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012
Figure 26: Planned Change in Staff Hiring Activities by Company Turnover (%), 2012
Figure 27: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2012
Figure 28: Global Pharmaceutical Industry: Top Five Emerging Markets, 2012
Figure 29: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012
Figure 30: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012
Figure 31: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012
Figure 32: Global Pharmaceutical Industry: Demand in Emerging Markets by Region (%), 2012
Figure 33: Global Pharmaceutical Industry: Demand in Emerging Markets by Turnover (%), 2012
Figure 34: Global Pharmaceutical Industry: Top Five Developed Countries Targeted for Growth, 2012
Figure 35: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012
Figure 36: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012
Figure 37: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012
Figure 38: Global Pharmaceutical Industry: Growth in Developed Countries by Region (%), 2012
Figure 39: Global Pharmaceutical Industry: Growth Expectations in Developed Countries by Turnover (% 'Increase' Responses), 2012
Figure 40: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012-2013
Figure 41: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012-2013
Figure 42: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012-2013
Figure 43: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012
Figure 44: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012
Figure 45: Actions to Maintain and Secure Buyer Business by Company Region (%), 2012
Figure 46: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012
Figure 47: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2012

Ask Your Question

Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: